Some patients with glioblastoma may benefit from epidermal growth factor receptor inhibition
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34547
Abstract: 4175 What are the clinical implications? One key clinical implication of these findings is the suggestion that TNBC cells can develop resistance against therapies, says Dr Grasset, explaining that cancer cell heterogeneity and EMT are… read more here.
Keywords: may benefit; cancer; benefit epidermal; glioblastoma may ... See more keywords